- Introduction of the related facilities and counseling clinics
- National Institutes for Quantum and Radiological Science and Technology, Hospital of the National Institute of Radiological Sciences
National Institute for Quantum and Radiological Science and Technology
QST Hospital (former NIRS Hospital)
Pioneer of Japanese heavy ion radiotherapy facilities: Over 11,000 patients have been treated
QST Hospital
4-9-1, Anagawa, Inage-ku, Chiba-shi, Chiba, Japan 263-8555
URL: https://www.nirs.qst.go.jp/hospital/en/
Access information
Inquiries about outpatient appointments
International Office
TEL: +81-43-206-3146
Features of the facility
- ・This facility provides medical services specializing in cancer radiation treatment and diagnosis as a hospital conducting radiotherapy-based research.
- ・This facility is equipped with Japan's first heavy ion beam irradiation system, HIMAC. Since 1994, when research and treatment began, it has conducted heavy ion radiotherapy on the most patients in Japan 11,834 (as of March 2019).
- ・The National Institute of Radiological Sciences (NIRS), which is the parent organization of this facility, has obtained favorable results from many fundamental studies on heavy ion beam medicine, and is in a leading position globally.
- ・While proactively attempting to increase the indications of heavy ion radiotherapy, this facility arranges a "comprehensive protocol" for patients for whom the therapy cannot be indicated.
Patient Enrolled in Carbon Ion Therapy at QST Hospital
Diseases targeted, and the estimated period of treatment
The cancers listed below are targeted; the "comprehensive protocol" is arranged to manage diseases other than these cancers as much as possible. The therapy cannot be unconditionally conducted for all diseases regardless of their condition. Depending on the disease, however, there are cases in which treatment in clinical studies is possible.
Diseases treated by advanced medical care
Disease | Estimate of the treatment period |
---|---|
Head and neck cancer: Nose, paranasal cavity, salivary gland, etc. | Four-week treatment |
Malignant melanoma (choroid of the eye) | One-week treatment |
Carcinoma in the lacrimal gland | Three-week treatment |
Lung cancer (non-small cell type): Locally advanced cancer | Three- to four-week treatment Treatment within one week for Stage I |
Liver cancer | Treatment within one week |
Pancreas cancer | Three-week treatment |
Prostate cancer | Three-week treatment |
Uterine cancer | Five-week treatment |
Rectal cancer (postoperative recurrence), difficult to operate | Four-week treatment |
Bone and soft tissue tumor, difficult to operate | Four-week treatment |
No other effective treatment despite distant metastasis | Partially favorable |
No harmful side effects in past radiotherapy | Partially favorable |
Diseases under clinical study:
Esophageal cancer, breast cancer, pancreas cancer (partial), metastatic liver cancer, kidney cancer, etc.